திசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from திசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In திசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜி Today - Breaking & Trending Today

Russian scientists 'developing new vaccine effective against ANY Covid mutation'


Russian scientists ‘developing new vaccine effective against ANY Covid mutation’
Will Stewart
Updated: 12:41 ET, Jun 4 2021
RUSSIAN scientists claim they have created a new vaccine “effective against ANY mutant strain of Covid .
Clinical trials are due to begin next month, said Tatyana Yakovleva, deputy head of Russia’s Federal Medical-Biological Agency (FMBA).

5
Russian scientists claim to be developing a superman vaccine against all Covid mutations
No matter what mutation [the SARS-CoV-2 coronavirus undergoes, the vaccine will keep protecting us from Covid-19.
Yakovleva claimed the vaccine was different to others because it creates humoural immunity (which lasts for no more than six months) for certain proteins, as the existing drugs do, and cell-mediated immunity. ....

United Kingdom , Sankt Peterburg , Natalya Yakovleva , Igor Borisevich , King Kong , Tatyana Yakovleva , Oxford Astrazeneca , Oxford Zeneca , Vladimir Putin , Boris Johnson , Vector State Research Centre Of Virology , Petersburg International Economic Forum , Federal Medical Biological Agency , Cold War , Vector State Research Centre , ஒன்றுபட்டது கிஂக்டம் , கிங் காங் , ஆக்ஸ்ஃபர்ட் ஸெநெக , விளாடிமிர் புட்டின் , போரிஸ் ஜான்சன் , திசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜி , பீட்டர்ஸ்பர்க் சர்வதேச பொருளாதார மன்றம் , குளிர் போர் , திசையன் நிலை ஆராய்ச்சி மையம் ,

Russian Health Ministry Authorizes Clinical Trials of EpiVacCorona-N Vaccine


https://sputniknews.com/russia/202104091082578578-russian-health-ministry-authorises-clinical-trials-of-epivaccorona-n-vaccine/
MOSCOW (Sputnik) - The Russian Health Ministry has authorized phase 1 and 2 clinical trials of EpiVacCorona-N, one more coronavirus vaccine developed by the Vector research center, according to the ministry s register.
An open study of the safety, tolerability, reactogenicity and immunising power of the EpiVacCorona-N peptide antigen-based vaccine for preventing COVID, involving volunteers aged 18-60 (phase 1-2), the register read.
The trials started on April 8 and are set to end on September 30.
The EpiVacCorona vaccine, developed by the Vector State Research Centre of Virology and Biotechnology, is a peptide-based drug that relies on a promising synthetic platform. It consists of artificially synthesised short fragments of viral proteins - peptides, through which the immune system learns how to recognise and then neutralise the virus. ....

Vector State Research Centre Of Virology , Vector State Research Centre , திசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜி , திசையன் நிலை ஆராய்ச்சி மையம் ,

Six promising Covid-19 vaccines set to join the immunisation race


Six promising Covid-19 vaccines set to join the immunisation race
From SpyBiotech’s “superglue” technology to Russia s next generation EpiVacCorona, dozens of vaccines are awaiting approval as nations step up efforts to overcome the pandemic
An older resident receives her first shot at Zabeel Health Centre on December 27, 2020. EPA
A Dubai ambulance worker is vaccinated in Dubai. EPA
The vaccine is expected to be rolled out to all age groups once people in the essential categories have been vaccinated. EPA
A nurse holds a dose of the Pfizer-BioNTech vaccine, which was approved for use by Dubai s emergency and crisis authority and the federal Ministry of Health. AFP ....

United Kingdom , South Africa , Sri Lanka , South African , Janssen Johnson , Polly Roy , John Bell , Spycatcher Spytag , Sanofi Glaxosmithkline , David Taylor , University College London , Vector State Research Centre Of Virology , University Of Oxford , London School Of Hygiene , European Union , Serum Institute Of India , Prof Polly Roy , London School , Tropical Medicine , Prof Roy , Prof David Taylor , University College , Bharat Biotech , Vector State Research Centre , Serum Institute , Sir John Bell ,

Prehistoric Animal Viruses From the Permafrost Caught Interest of Russian Scientists


Close
Scientists are examining prehistoric viruses from the Siberian permafrost in the animal dug. A lab in Russia s Siberia state is beginning study about prehistoric viruses conserved in the remnants of animals discovered in melting permafrost.
 Led by the Biotechnology,  University of Yakutsk and Vector State Research Centre of Virology, the research will begin by examining tissues from a prehistoric horse from at most 4,500 years ago.
These remnants were found in Yakutia, an area of Siberia, where Paleolithic animals such as mammoths are frequently seen.
(Photo : Maria Orlova)
Other Prehistoric Animals 
 The scientists strive to research other prehistoric animals including rodents, partridges, hares, elk, dogs, the 28,800-year-old Malolyakhovsky woolly mammoth, and more. Several of the remnants are above 50,000 years old. All the animals were discovered because of the thawing. ....

Sakha Yakutiya , Novosibirskaya Oblast , Olesya Okhlopkova , Maria Orlova , Eberhard Grossgas , Vector Virology Centre , Vector State Research Centre Of Virology , Museum Laboratory , University Of Yakutsk , Yakutsk University Maxim Cheprasov , Research On Prehistoric Animals , Vector State Research Centre , Prehistoric Animals , Mammoth Museum , Yakutsk University Maxim , Surface Out , Prehistoric Animal , Arctic Permafrost Brings Long Dead Viruses , Nature World , திசையன் வைராலஜி மையம் , திசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜி , அருங்காட்சியகம் ஆய்வகம் , ஆராய்ச்சி ஆன் ப்ரிஹிஸ்டாரிக் விலங்குகள் , திசையன் நிலை ஆராய்ச்சி மையம் , ப்ரிஹிஸ்டாரிக் விலங்குகள் , மாமத் அருங்காட்சியகம் ,